Weight and non-insulin-dependent diabetes mellitus

American Journal of Clinical Nutrition

Volumn 63, Issue 3 SUPPL., 1996, Pages

  Pi Sunyer, F Xavier ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

body mass index; Diabetes; obesity; weight

Indexed keywords

BODY MASS; CONFERENCE PAPER; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK ASSESSMENT; WEIGHT REDUCTION;

EID: 0029966681     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/63.3.426     Document Type: Conference Paper

References (53)

1. West KM. Kalbfleish JM. Influence of nutritional factors on prevalence of diabetes. Diabetes 1971:20:99-108.
2. Hundley JM. Diabetes; overweight: U.S. problems. J Am Diet Assoc 1956;32:417-22.
3. Van Itallie T. Health implications of overweight and obesity in the United States. Ann Intern Med 1985;103:983-8.
4. Knowler WC, Pettit DJ, Saad MF, Bennett PH. Diabetes mellitus in the Puna Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev 1990;6:1-27.
5. Westlund K, Nicolaysen R. Ten-year mortality related to serum cholesterol: a followup of 3751 men aged 40-49. Scand J Clin Lab Invest 1972;30:1-24.
6. Cassano PA, Rosner B, Vokonas PS, Weiss ST. Obesity and body fat distribution in relation to the incidence of non-insulin-dependent diabetes mellitus. A prospective cohort study of men in the Normative Aging Study. Am J Epidemiol 1992;136:1474-86.
7. Colditz GA, Willett WC, Stampfer MJ, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990;132:501-13.
8. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956;4:20-34.
9. Hartz AJ, Rupley DC, Kalkhoff RD, Rimm AA. Relationship of obesity to diabetes: influence of obesity level and body fat distribution. Prev Med 1983;12:351-7.
10. Sparrow D, Borkan G, Gerzof S, Wisniewski C. Silbert C. Relationship of fat distribution to glucose tolerance. Diabetes 1986;35:411-5.
11. Gillum R. The association of body fat distribution with hypertension, hypertensive heart disease, coronary heart disease, diabetes and cardiovascular risk factors in men and women aged 18-79 years. J Chronic Dis 1987;40:421-8.
12. Ohlson L, Larsson B, Svardsudd K, et al. The influence of body fat distribution on the incidence of diabetes mellitus. Diabetes 1985;34: 1055-8.
13. Lundgren H, Bengtsson C, Blohme G, Lapidus L, Sjostrom L. Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: results from a prospective population study in Gothenburg, Sweden. Int J Obes 1989;13:413-23.
14. Haffner S, Mitchell B, Hazuda H, Stern M. Greater influence of central distribution of adipose tissue on incidence of non-insulin-dependent diabetes in women than men. Am J Clin Nutr 1991;53:1312-7.
15. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 years. Diabetes 1987;36:523-34.
16. Shimokata H, Tobin JD, Muller DC, et al. Studies in the distribution of body fat: I. Effects of age, sex, and obesity. J Gerontol 1989;44: M66-73.
17. Nagulesparan M, Savage PJ, Unger RH, Bennet PH. A simplified method using somatostatin to assess in vivo insulin resistance over a range of obesity. Diabetes 1979;28:980-3.
18. Olefsky JM, Kolterman OG. Mechanisms of insulin resistance in obesity and non-insulin dependent (type II) diabetes. 1986;17:684-92.
19. Bistrian BR, Blackburn G, Ran J, Sizer J, Scrimshaw NS, Sherman M. Nitrogen metabolism and insulin requirements in obese diabetic adults on a protein-sparing modified fast. Diabetes 1976;25:494-504.
20. Savage PJ, Bennion LJ, Flock EV, et al. Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus. J Clin Endocrinol Metab 1979;48:999-1007.
21. Fitz JD, Sperling EM, Fein HG. A hypocaloric high-protein diet as primary therapy for adults with obesity-related diabetes: effective long-term use in a community hospital. Diabetes Care 1983;6 328-33.
22. Hughes TA, Gwymme JT, Switzer BR, Herbst C, White G. Effects of caloric restriction and weight loss on glycémie control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus. Am J Med 1984;77:7-17.
23. Amatruda JM, Richeson F, Welle SL, Brodows RG, Lockwood DH. The safety and efficacy of a controlled low-energy ('very-low-calorie') diet in the treatment of non-insulin-dependent diabetes and obesity. Arch Intern Med 1988;148:873-7.
24. Henry RR, Wallace P, Olefsky JM. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes 1986;35:990-8.
25. Wing RR, Koeske R, Epstein LH, Nowalk MP, Gooding W, Becker D. Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 1987;147:1749-53.
26. Wing RR, Schoemaker M, Marcus MD, McDermort M, Gooding W Variables associated with weight loss and improvements in glycemic control in type II diabetic patients in behavioral weight control programs, Int J Obes 1990;14:495-503.
27. UKPDS Group. UK prospective diabetes study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients. Metabolism 1990;33:905-12.
28. Henry RR, Gumbiner B. Benefits and limitations of very-low-calorie diet therapy in obese NIDDM. Diabetes Care 1991;14:802-23.
29. Beck-Nielsen H, Pedersen O, Sorensen NS. Effects of dietary changes on cellular insulin binding and in vivo insulin sensitivity. Metabolism 1980;29:482-7.
30. Friedman JE, Dohm GL, Leggett-Frazier N, et al. Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4. J Clin Invest 1992;89:701-5.
31. Freidenberg GR, Reichart D, Olefsky JM, Henry RR. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. J Clin Invest 1988;82:1398-406.
32. Porte D Jr. β-cells in type II diabetes mellitus. Diabetes 1991;40:166-80.
33. DeFronzo RA. The triumvirate: beta cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667-87.
34. Dimitriadis G, Cryer P, Gerich J. Prolonged hyperglycemia during infusion of glucose and somatostatin impairs pancreatic A and B-cell responses to decrements in plasma glucose in normal man: evidence of induction of altered sensitivity to glucose. Diabetologia 1985;28:63-9.
35. Leahy JL, Cooper HE, Deal DA. Weir GC. Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. J Clin Invest 1986;77:908-15.
36. Long SD, O'Brien K, McDonald KG, et al. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type 2 diabetes. Diabetes Care 1994;5:372-5.
37. Colditz GA, Willett WC, Stampfer MJ, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990,132:501-13.
38. Eriksson KF, Lindgarde F. Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise: the 6-year Malmo feasibility study. Diabetologia 1991;34:891-8.
39. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975;55:845-55.
40. American Diabetes Association. Medical management of non-insulin-dependent diabetes. 3rd ed. Alexandria, VA: American Diabetes Association, 1994.
41. Staessen J, Fagard R, Lijnen P, Amery A. Body weight, sodium intake and blood pressure. J Hypertens 1989;7(suppl 1):S19-23.
42. Fagerberg B, Anderson OK, Persson B, Hedner T. Reactivity to norepinephrine and effect of sodium on blood pressure during weight loss. Hypertension 1985;7:586-92.
43. Reisin E, Abel R, Modan M. Silverberg DS, Eliahou HE, Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med 1978;298: 1-6.
44. Uusitupa MIJ, Laakso M, Sarlund H, Majander H, Takala J. Penttila I. Effects of a very-low-calorie diet on metabolic control and cardiovascular risk factors in the treatment of obese non-insulin-dependent diabetics. Am J Clin Nutr 1990;51:768-73.
45. American Diabetes Association. Detection and management of lipid disorders in diabetes. Diabetes Care 1993;16:828-34.
46. Greenfield M, Kolterman O, Olefsky JM, Reaven GM. Mechanism of hypertnglyceridemia in diabetic patients with fasting hypertriglyceridemia. Diabetologia 1980;18:441-6.
47. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987;28:613-28.
48. Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM. LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb 1992;12:1496-502.
49. Ginsberg HN. Lipoprotein physiology in nondiabetic and diabetic states: relationship to atherogenesis. Diabetes Care 1991;14:839-55.
50. Garg A, Grundy SM. Management of dyslipidemia in NIDDM. Diabetes Care 1990;13.153-69.
51. Kennedy L, Washe K, Hadden DR, Weaver JA, Buchanan KD. The effect of intensive dietary therapy on serum high density lipoproteincholesterol in patients with type 2 non-insulin-dependent diabetes mellitus: a prospective study. Diabetologia 1982;23:24-7.
52. Howard BV, Savage PJ, Nagulesparan M, Bennion LJ, Davis M, Bennett P. Changes in plasma lipoproteins accompanying diet therapy in obese diabetics. Atherosclerosis 1979;33:445-56.
53. Lean MEJ, Powrie JK, Anderson AS, Garthwaite PH. Obesity. weight loss and prognosis in type 2 diabetes. Diabet Med 1990;7: 228-33.